Literature DB >> 22051336

Reduced collagen deposition in infarcted myocardium facilitates induced pluripotent stem cell engraftment and angiomyogenesis for improvement of left ventricular function.

Bo Dai1, Wei Huang, Meifeng Xu, Ronald W Millard, Mei Hua Gao, H Kirk Hammond, Donald R Menick, Muhammad Ashraf, Yigang Wang.   

Abstract

OBJECTIVES: The purpose of this study was to assess the effect of scar tissue composition on engraftment of progenitor cells into infarcted myocardium.
BACKGROUND: Scar tissue formation after myocardial infarction creates a barrier that severely compromises tissue regeneration, limiting potential functional recovery.
METHODS: In vitro: A tricell patch (Tri-P) was created from peritoneum seeded and cultured with induced pluripotent stem cell-derived cardiomyocytes, endothelial cells, and mouse embryonic fibroblasts. The expression of fibrosis-related molecules from mouse embryonic fibroblasts and infarcted heart was measured by Western blot and quantitative reverse transcriptase polymerase chain reaction. In vivo: A Tri-P was affixed over the entire infarcted area 7 days after myocardial infarction in mice overexpressing adenylyl cyclase 6 (AC6). Engraftment efficiency of progenitor cells in hearts of AC6 mice was compared with that of control wild-type (WT) mice using a combination of in vivo bioluminescence imaging, post-mortem ex vivo tissue analysis, and the number of green fluorescent protein-positive cells. Echocardiography of left ventricular (LV) function was performed weekly. Hearts were harvested for analysis 4 weeks after Tri-P application. Mouse embryonic fibroblasts were stimulated with forskolin before an anoxia/reoxygenation protocol. Fibrosis-related molecules were analyzed.
RESULTS: In AC6 mice, infarcted hearts treated with Tri-P showed significantly higher bioluminescence imaging intensity and numbers of green fluorescent protein-positive cells than in WT mice. LV function improved progressively in AC6 mice from weeks 2 to 4 and was associated with reduced LV fibrosis.
CONCLUSIONS: Application of a Tri-P in AC6 mice resulted in significantly higher induced pluripotent stem cell engraftment accompanied by angiomyogenesis in the infarcted area and improvement in LV function. Copyright Â
© 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22051336      PMCID: PMC3342759          DOI: 10.1016/j.jacc.2011.06.062

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  20 in total

Review 1.  Potential of stem-cell-based therapies for heart disease.

Authors:  Deepak Srivastava; Kathryn N Ivey
Journal:  Nature       Date:  2006-06-29       Impact factor: 49.962

2.  Porous tissue grafts sandwiched with multilayered mesenchymal stromal cell sheets induce tissue regeneration for cardiac repair.

Authors:  Chun-Hung Chen; Hao-Ji Wei; Wei-Wen Lin; Iwen Chiu; Shiaw-Min Hwang; Chung-Chi Wang; Wen-Yu Lee; Yen Chang; Hsing-Wen Sung
Journal:  Cardiovasc Res       Date:  2008-06-06       Impact factor: 10.787

3.  Adenylyl cyclase type 6 deletion decreases left ventricular function via impaired calcium handling.

Authors:  Tong Tang; Mei Hua Gao; N Chin Lai; Amy L Firth; Toshiyuki Takahashi; Tracy Guo; Jason X-J Yuan; David M Roth; H Kirk Hammond
Journal:  Circulation       Date:  2007-12-10       Impact factor: 29.690

4.  Identification of the Raf-1 signaling pathway used by cAMP to inhibit p42/p44 MAPK in rat lacrimal gland acini: role in potentiation of protein secretion.

Authors:  Chika Funaki; Robin R Hodges; Darlene A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-07-29       Impact factor: 4.799

5.  cAMP inhibits transforming growth factor-beta-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1/2 and Smad signaling in cardiac fibroblasts.

Authors:  Xiaoqiu Liu; Shu Qiang Sun; Aviv Hassid; Rennolds S Ostrom
Journal:  Mol Pharmacol       Date:  2006-09-07       Impact factor: 4.436

Review 6.  Clinical aspects of hypertensive myocardial fibrosis.

Authors:  J Díez; B López; A González; R Querejeta
Journal:  Curr Opin Cardiol       Date:  2001-11       Impact factor: 2.161

7.  Adenylyl cyclase activity and function are decreased in rat cardiac fibroblasts after myocardial infarction.

Authors:  James S Swaney; Hemal H Patel; Utako Yokoyama; N Chin Lai; Matthew Spellman; Paul A Insel; David M Roth
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-09-14       Impact factor: 4.733

8.  cAMP-elevating agents and adenylyl cyclase overexpression promote an antifibrotic phenotype in pulmonary fibroblasts.

Authors:  Xiaoqiu Liu; Rennolds S Ostrom; Paul A Insel
Journal:  Am J Physiol Cell Physiol       Date:  2004-01-07       Impact factor: 4.249

9.  Activation of cardiac adenylyl cyclase expression increases function of the failing ischemic heart in mice.

Authors:  N Chin Lai; Tong Tang; Mei Hua Gao; Miho Saito; Toshiyuki Takahashi; David M Roth; H Kirk Hammond
Journal:  J Am Coll Cardiol       Date:  2008-04-15       Impact factor: 24.094

Review 10.  Wound repair and regeneration.

Authors:  Geoffrey C Gurtner; Sabine Werner; Yann Barrandon; Michael T Longaker
Journal:  Nature       Date:  2008-05-15       Impact factor: 49.962

View more
  31 in total

Review 1.  Cardiovascular Bio-Engineering: Current State of the Art.

Authors:  Teresa Simon-Yarza; Isabelle Bataille; Didier Letourneur
Journal:  J Cardiovasc Transl Res       Date:  2017-03-06       Impact factor: 4.132

Review 2.  Prospects for gene transfer for clinical heart failure.

Authors:  T Tang; M H Gao; H Kirk Hammond
Journal:  Gene Ther       Date:  2012-04-26       Impact factor: 5.250

3.  Heterogeneity of adult masseter muscle satellite cells with cardiomyocyte differentiation potential.

Authors:  Wei Huang; Jialiang Liang; Yuliang Feng; Zhanfeng Jia; Lin Jiang; Wenfeng Cai; Christian Paul; Jianguo G Gu; Peter J Stambrook; Ronald W Millard; Xiao-Lan Zhu; Ping Zhu; Yigang Wang
Journal:  Exp Cell Res       Date:  2018-05-26       Impact factor: 3.905

4.  Human Embryonic Stem Cell-Derived Cardiovascular Progenitors Repair Infarcted Hearts Through Modulation of Macrophages via Activation of Signal Transducer and Activator of Transcription 6.

Authors:  Jinxi Wang; Meilan Liu; Qiang Wu; Qiang Li; Ling Gao; Yun Jiang; Boxiong Deng; Wei Huang; Wei Bi; Zhongyan Chen; Y Eugene Chin; Christian Paul; Yigang Wang; Huang-Tian Yang
Journal:  Antioxid Redox Signal       Date:  2019-04-16       Impact factor: 8.401

5.  Decreased expression of adenosine receptor 2B confers cardiac protection against ischemia via restoring autophagic flux.

Authors:  Enbo Zhan; Wei Cao; Xiaoying Fan; Ruoxi Zhang; Hongwei Du; Yousheng Xu; Lili Li; Nana Dong; Shaojun Li
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

Review 6.  Cardiac stem cells and their roles in myocardial infarction.

Authors:  Jingying Hou; Lingyun Wang; Jieyu Jiang; Changqing Zhou; Tianzhu Guo; Shaoxin Zheng; Tong Wang
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

7.  Acute preconditioning of cardiac progenitor cells with hydrogen peroxide enhances angiogenic pathways following ischemia-reperfusion injury.

Authors:  Karl D Pendergrass; Archana V Boopathy; Gokulakrishnan Seshadri; Kathryn Maiellaro-Rafferty; Pao Lin Che; Milton E Brown; Michael E Davis
Journal:  Stem Cells Dev       Date:  2013-05-25       Impact factor: 3.272

8.  Suicide gene-mediated sequencing ablation revealed the potential therapeutic mechanism of induced pluripotent stem cell-derived cardiovascular cell patch post-myocardial infarction.

Authors:  Yuhua Wang; Wei Huang; Jialiang Liang; Zhili Wen; Dehua Chang; Kai Kang; Jiapeng Wang; Meifeng Xu; Ronald W Millard; Yigang Wang
Journal:  Antioxid Redox Signal       Date:  2014-08-13       Impact factor: 8.401

Review 9.  Potential of cardiac stem/progenitor cells and induced pluripotent stem cells for cardiac repair in ischaemic heart disease.

Authors:  Wei Eric Wang; Xiongwen Chen; Steven R Houser; Chunyu Zeng
Journal:  Clin Sci (Lond)       Date:  2013-10       Impact factor: 6.124

Review 10.  Pluripotent Stem Cell Therapy in Ischemic Cardiovascular Disease.

Authors:  Ting-Hsing Chao; I-Chih Chen; Shi-Ya Tseng; Yi-Heng Li
Journal:  Acta Cardiol Sin       Date:  2014-09       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.